Table 2.
The relationship between the development of visual symptoms, the presence of anti-transducin-α autoantibodies and diagnosis of cancer in our cohort of patients
Case # | Sex/Age | Time of Antibody Testing | Onset of Visual Symptoms | Onset of Cancer | Time of Cancer Diagnosis to Retinopathy Onset | Cancer Type |
---|---|---|---|---|---|---|
1 | F/63 | 5/2006 | 2006 | 1999 | 7 years | breast metastatic small cell carcinoma of |
2 | F/70 | 3/2007 | 1/2007 | 2007 | 1 month | the lung |
3 | F/45 | 5/2004 | 2003 | 2002 | 1 year | skin |
4 | F/48 | 3/2007 | 2007 | NA | melanoma metastatic | |
5 | F/73 | 3/2007 | 2005 | 2005 | months | skin |
6 | F/89 | 4/2006 | 2006 | 2005 | 1 year | uterine |
14 | F/86 | 3/2006 | 2005 | 2006 | - 1 year | colon |
26 | M/69 | 10/2000 | 2000 | NA | colon, skin | |
27 | M/54 | 6/2000 | 1/2000 | 1994 | 6 years | skin non-small carcinoma of |
28 | M/75 | 9/2006 | 2006 | 2002 | 4 years | the lung |
29 | M/80 | 2/2007 | 2007 | 2004 | 3 years | prostate |
NA – not available; Case numbers as in Table 1